drugset / Trial / NCT00098631
Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
NaSingle-groupOpen-labelTreatment
Summary
Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth. This phase II trial is studying how well lapatinib works in treating patients with recurrent and/or metastatic head and neck cancer.
Timeline
- Start
- 2004-10
- Primary completion
- 2006-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapatinib | Small molecule | — | Oral |